Thomas J. Meade, PhD

Dr. Meade is a highly successful inventor and entrepreneur, a founder of several tech companies worth hundreds of millions. He received his Ph.D. in Inorganic Chemistry from The Ohio State University. After completing postdoctoral fellowships at Harvard Medical School, and California Institute of Technology, he joined the Division of Biology and the Beckman Institute at Caltech. In 2003, he moved to Northwestern University where he is currently the Eileen Foell Chair in Cancer Research and Professor of Chemistry, Biochemistry and Molecular & Cell Biology, Neurobiology & Physiology, and Radiology, as well as the Director of the Center for Advanced Molecular Imaging (CAMI). Professor Meade’s research focuses on bioinorganic coordination chemistry and its application in research that include biological molecular imaging, electron transfer processes and the development of electronic biosensors for the detection of DNA and proteins. He has received numerous awards and founded three biotech companies, Clinical Micro Sensors, PreDx and Ohmx which are developing hand-held devices for protein and DNA detection and bioactivated MR contrast agents for in vivo imaging of cancer. Dr. Meade is widely recognized as a world-leading expert in MRI imaging applications in research and development.